Our expert Faculty discussed the potential roles of biomarkers of nerve damage (neurofilaments), energy storage and metabolism within muscles and disease specific biomarkers in clinical practice. Learn more about the speakers and what they discussed at the symposium, and find links to more information.
NM, MBBS, PhD, DSc, FRACP, FAHMS (Chair)
University of Sydney and Royal Prince Alfred Hospital, Sydney, NSW, Australia
neurofilaments in ALS
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
neurofilaments in SMA
University Hospitals Leuven, Leuven, Belgium
“Serum creatine kinase and
creatinine in adult spinal
Technische Universität Dresden (TUD), Dresden, Germany
As noted at Biogen’s WMS symposium, biology and genetics have significant implications for the clinical practices around SMA.
For more about ALS, visit Biogen's website, insideALS: A resource for EU healthcare professionals interested in learning more about the rapidly changing science of ALS, featuring content co-created with key medical experts in the field.
Learn more about Biogen's participation in
NMD and Neurology events
Check out the Biogen-sponsored symposia, publications and posters about SMA from this and past congresses at:
1. Lefebvre S, Bürglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80(1):155-165.
2. Medline Plus. Genetics Home Reference. SMN1. [online] 2016 Apr 20 [cited 2020 Sept 30]. Available from: URL: https://ghr.nlm.nih.gov/gene/SMN1.
3. MedlinePlus. Medical Encyclopedia. Spinal muscular atrophy. [online] [cited 2020 Sep 30]. Available from: URL: https://medlineplus.gov/ency/article/000996.htm.